Rapid testing of C. diff patients

Triggered by antibiotic use, Clostridium difficile is the main cause of hospitalacquired diarrhoea. INVERNESS MEDICAL has introduced two new rapid tests.

TechLab TOX A/B Quik Chek and BioStar OIA CdTOX AB enable swift diagnosis and subsequent isolation of patients, reducing cross contamination in clinical areas. Delivering results in minutes, both tests qualitatively detect C. difficile Toxins A and B directly from human faecal specimens.

Clinical symptoms of C. difficile associated disease (CDAD) were once thought to be solely due to Toxin A. However, there is growing evidence that Toxin B may also play an important role in the pathogenesis of C. difficile. According to Inverness Medical’s VP International Business, David Walton, it is becoming mandatory in an increasing number of countries to use a test that detects both toxins.

A positive or negative result can be achieved in approximately 10 minutes.

Latest Issues

EBME Expo 2025

Coventry Building Society Arena, UK
25th - 26th June 2025

AfPP Annual National Conference

University of Warwick
8th - 9th August 2025

Clinical Engineering Conference

Stansted Radisson Blu
23rd September 2025

Infection Prevention 2025

Brighton Centre, UK
29th - 30th September 2025